HERAMED LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.014 AUD | -6.67% |
|
-22.22% | -41.67% |
| May. 20 | HeraMED Appoints Auditor | MT |
| May. 13 | Transcript : HeraMED Limited - Special Call |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 219K 328K | Sales 2023 | 403K 605K | Capitalization | 5.25M 7.88M |
|---|---|---|---|---|---|
| Net income 2022 | -4M -6M | Net income 2023 | -4M -6M | EV / Sales 2022 | 83.2 x |
| Net cash position 2022 | 2.46M 3.69M | Net cash position 2023 | 575K 863K | EV / Sales 2023 | 11.6 x |
| P/E ratio 2022 |
-3.74
x | P/E ratio 2023 |
-0.95
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on HeraMED Limited
More recommendations
More news
| 1 day | -6.67% | ||
| 1 week | -22.22% | ||
| Current month | -20.00% | ||
| 1 month | -20.00% | ||
| 3 months | -26.32% | ||
| 6 months | -69.57% | ||
| Current year | -41.67% |
1 week
0.01
0.02
1 month
0.010.02
Current year
0.010.03
1 year
0.010.09
3 years
0.010.34
5 years
0.010.34
10 years
0.010.34
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 22-06-30 | |
Michal Yardeny
ADM | Chief Administrative Officer | - | - |
Nir Pearl
COO | Chief Operating Officer | - | 22-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Hinton
BRD | Director/Board Member | 60 | 18-08-20 |
Timothy Chapman
CHM | Chairman | - | Mar. 10 |
| Chief Executive Officer | - | 22-06-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-21 | 0.014 | -6.67% | 1 259 520 |
| 24-05-20 | 0.015 | 0.00% | 688,828 |
| 24-05-17 | 0.015 | -6.25% | 612,838 |
| 24-05-16 | 0.016 | +6.67% | 1,078,116 |
| 24-05-15 | 0.015 | 0.00% | 952,111 |
Delayed Quote Australian S.E., May 21, 2024 at 02:10 am EDT
More quotes
Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetusâ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.
Calendar
2024-05-29
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -41.67% | 3.54M | |
| -14.26% | 2.88B | |
| +1.74% | 188M | |
| +13.04% | 50.96M |
- Stock Market
- Equities
- HMD Stock